Legend Biotech Corp Stock Analysis

LEGN Stock  USD 59.67  0.21  0.35%   
Legend Biotech Corp is undervalued with Real Value of 71.58 and Target Price of 88.36. The main objective of Legend Biotech stock analysis is to determine its intrinsic value, which is an estimate of what Legend Biotech Corp is worth, separate from its market price. There are two main types of Legend Biotech's stock analysis: fundamental analysis and technical analysis.
The Legend Biotech stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Legend Biotech is usually not traded on Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday. Legend Stock trading window is adjusted to America/New York timezone.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Legend Biotech Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

Legend Stock Analysis Notes

About 49.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 2.58. Legend Biotech Corp had not issued any dividends in recent years. Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Legend Biotech Corporation is a subsidiary of Genscript Biotech Corporation. Legend Biotech operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 1071 people. To find out more about Legend Biotech Corp contact Ying Huang at 732 317 5050 or learn more at https://www.legendbiotech.com.

Legend Biotech Quarterly Total Revenue

93.99 Million

Legend Biotech Corp Investment Alerts

Legend Biotech Corp appears to be risky and price may revert if volatility continues
The company reported the previous year's revenue of 285.14 M. Net Loss for the year was (518.25 M) with loss before overhead, payroll, taxes, and interest of (284.01 M).
Legend Biotech Corp currently holds about 791.26 M in cash with (384.47 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.11.
Latest headline from zacks.com: Legend Biotech Up 12 percent on Reports of Takeover Bid

Legend Biotech Corp Upcoming and Recent Events

Earnings reports are used by Legend Biotech to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
4th of April 2024
Upcoming Quarterly Report
View
16th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
4th of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Legend Largest EPS Surprises

Earnings surprises can significantly impact Legend Biotech's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2021-05-18
2021-03-31-0.35-0.30.0514 
2022-12-14
2022-09-30-0.31-0.37-0.0619 
2021-03-18
2020-12-31-0.28-0.220.0621 
View All Earnings Estimates

Legend Biotech Environmental, Social, and Governance (ESG) Scores

Legend Biotech's ESG score is a quantitative measure that evaluates Legend Biotech's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Legend Biotech's operations that may have significant financial implications and affect Legend Biotech's stock price as well as guide investors towards more socially responsible investments.

Legend Stock Institutional Investors

Shares
Massachusetts Financial Services Company2024-03-31
1.9 M
Federated Hermes Inc2024-03-31
1.5 M
Braidwell Lp2024-03-31
1.2 M
Timessquare Capital Management, Llc2024-03-31
1.2 M
Alliancebernstein L.p.2024-03-31
1.1 M
State Street Corporation2024-03-31
M
Arrowmark Colorado Holdings, Llc (arrowmark Partners)2024-03-31
M
Johnson & Johnson2024-03-31
814.6 K
Holocene Advisors, Lp2024-03-31
761.6 K
Fmr Inc2024-03-31
16.1 M
T. Rowe Price Associates, Inc.2024-03-31
10.9 M
Note, although Legend Biotech's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Legend Market Capitalization

The company currently falls under 'Large-Cap' category with a current market capitalization of 10.92 B.

Legend Profitablity

The company has Profit Margin (PM) of (1.36) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.25) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.25.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.31)(0.32)
Return On Capital Employed(0.27)(0.28)
Return On Assets(0.28)(0.29)
Return On Equity(0.41)(0.43)

Management Efficiency

Legend Biotech Corp has return on total asset (ROA) of (0.1825) % which means that it has lost $0.1825 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5128) %, meaning that it created substantial loss on money invested by shareholders. Legend Biotech's management efficiency ratios could be used to measure how well Legend Biotech manages its routine affairs as well as how well it operates its assets and liabilities. As of the 24th of July 2024, Return On Tangible Assets is likely to drop to -0.32. In addition to that, Return On Capital Employed is likely to drop to -0.28. At this time, Legend Biotech's Net Tangible Assets are very stable compared to the past year. As of the 24th of July 2024, Intangible Assets is likely to grow to about 163 M, while Total Assets are likely to drop about 938.8 M.
Last ReportedProjected for Next Year
Book Value Per Share 7.11  7.46 
Tangible Book Value Per Share 6.27  6.58 
Enterprise Value Over EBITDA(22.87)(24.01)
Price Book Value Ratio 8.47  8.04 
Enterprise Value Multiple(22.87)(24.01)
Price Fair Value 8.47  8.04 
Enterprise Value9.6 B5.2 B
The analysis of Legend Biotech's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Legend Biotech's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Legend Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Operating Margin
(1.25)
Profit Margin
(1.36)
Beta
0.111
Return On Assets
(0.18)
Return On Equity
(0.51)

Technical Drivers

As of the 24th of July, Legend Biotech secures the Mean Deviation of 2.45, risk adjusted performance of 0.096, and Downside Deviation of 3.15. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Legend Biotech Corp, as well as the relationship between them.

Legend Biotech Corp Price Movement Analysis

Execute Study
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Legend Biotech middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Legend Biotech Corp. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Legend Biotech Outstanding Bonds

Legend Biotech issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Legend Biotech Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Legend bonds can be classified according to their maturity, which is the date when Legend Biotech Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Legend Biotech Predictive Daily Indicators

Legend Biotech intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Legend Biotech stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Legend Biotech Corporate Filings

6K
17th of July 2024
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
6K
2nd of July 2024
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
6K
3rd of June 2024
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
6K
23rd of May 2024
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
6K
13th of May 2024
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
6K
22nd of April 2024
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
6K
16th of April 2024
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
6K
8th of April 2024
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify

Legend Biotech Forecast Models

Legend Biotech's time-series forecasting models are one of many Legend Biotech's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Legend Biotech's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Legend Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Legend Biotech prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Legend shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Legend Biotech. By using and applying Legend Stock analysis, traders can create a robust methodology for identifying Legend entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(1.82)(1.92)
Operating Profit Margin(1.55)(1.63)
Net Loss(1.82)(1.91)
Gross Profit Margin 0.42  0.44 

Current Legend Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Legend analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Legend analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
88.36Strong Buy21Odds
Legend Biotech Corp current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Legend analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Legend stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Legend Biotech Corp, talking to its executives and customers, or listening to Legend conference calls.
Legend Analyst Advice Details

Legend Stock Analysis Indicators

Legend Biotech Corp stock analysis indicators help investors evaluate how Legend Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Legend Biotech shares will generate the highest return on investment. By understating and applying Legend Biotech stock analysis, traders can identify Legend Biotech position entry and exit signals to maximize returns.
Begin Period Cash Flow787.3 M
Long Term Debt281.3 M
Common Stock Shares Outstanding176.1 M
Total Stockholder Equity1.3 B
Tax Provision283 K
Property Plant And Equipment Net189.7 M
Cash And Short Term Investments1.3 B
Cash1.3 B
Accounts Payable20.2 M
Net Debt-949.4 M
50 Day M A45.9896
Total Current Liabilities216.4 M
Other Operating Expenses727.4 M
Non Current Assets Total350.8 M
Non Currrent Assets Other152.4 M
Stock Based Compensation47.7 M

Additional Information and Resources on Investing in Legend Stock

When determining whether Legend Biotech Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Legend Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Legend Biotech Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Legend Biotech Corp Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Legend Biotech Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Legend Biotech. If investors know Legend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Legend Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.58)
Revenue Per Share
1.902
Quarterly Revenue Growth
1.587
Return On Assets
(0.18)
Return On Equity
(0.51)
The market value of Legend Biotech Corp is measured differently than its book value, which is the value of Legend that is recorded on the company's balance sheet. Investors also form their own opinion of Legend Biotech's value that differs from its market value or its book value, called intrinsic value, which is Legend Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Legend Biotech's market value can be influenced by many factors that don't directly affect Legend Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Legend Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Legend Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Legend Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.